(Date:12/16/2009)... /PRNewswire/ -- Capitalizing on the ... and an active venture capital market, leaders from ... Retirement Fund, Indiana University, Purdue University, the University ... Credit Suisse today announced the establishment of the ... of funds. ,, Organized through BioCrossroads, Indiana,s initiative ...
(Date:12/16/2009)... InVitria has what scientists have been asking for! Zap-CHO is ... growth and productivity of CHO cells. Developed for scientists seeking ... well defined and consistent recombinant CHO supplement. , ... ... -- Scientists working with CHO cells can now access an ...
(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...
(Date:12/15/2009)... CHARLOTTESVILLE, Va., Dec. 15 AstraZeneca ... University of Virginia (UVa) in Charlottesville, today ... strategic research collaboration to enhance development of ... (CAD) with a secondary focus on peripheral ... ) ,, The collaborative preclinical research ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3... Baxter Healthcare Corporation,today announced its V-Link Luer-activated ... needleless intravenous (IV) connector to,contain an antimicrobial ... the,United States and Canada. V-Link with VitalShield ... percent or more of specific common pathogens,(infection-causing ...
... held by American Red Cross, in a ... PRDT to 77%, - American Red Cross to remain ... MONTREAL and CAMBRIDGE, England, April 9 /PRNewswire-FirstCall/ -,ProMetic Life ... Letter of Intent ("LOI") to acquire the American Red ...
... CALGARY, April 9 /PRNewswire-FirstCall/ - Oncolytics Biotech ... from its U.K. combination REOLYSIN(R) and carboplatin/paclitaxel,trial. ... Cancer Research, London,and the principal investigator for ... 5th Annual Conference of the British Society ...
Other Biology Technology:Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 2Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 3Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc. 7Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial 3(Date:12/16/2009)... IgeaCare Solutions Inc. is pleased to ... healthcare communications company previously operating as IgeaCare Systems ... move forward under new leadership and funding. ,, ... to the position of Chief Executive Officer. Under ... providing a superior servicing and support model; fast ...
(Date:12/15/2009)... LONDON, Dec. 15 The 2009 ... Innovation Award is presented to Sagem Securite ... Control systems. The award recognises the company,s ... continuous stewardship in offering novel, value-added products ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, "Sagem Securite has ...
(Date:12/15/2009)... Inc. GenWay Clinical Laboratory, San Diego, California, has ... American Pathologists (CAP), based on results of a ... director was advised of this national recognition and ... provided." GenWay Biotech Inc. GenWay Clinical Laboratory is ... The CAP Laboratory Accreditation Program, begun in the ...
Breaking Biology News(10 mins):IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Rules Based Medicine Inc Names Tony Barnes to Lead Expanding Diagnostics Business 47592 1Rules Based Medicine Inc Names Tony Barnes to Lead Expanding Diagnostics Business 47592 2AARP to Support the Love Avon Army of Women 47587 1AARP to Support the Love Avon Army of Women 47587 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 1Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 3...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
Handles samples from from 75l to 150l...
Hybridization chamblers suitable for use with all ChIP-GLAS microarrays....
Biology Products:Biology NavigationMedical Navigation